Search company, investor...
Green Biologics company logo

Green Biologics

Founded Year



Debt | Alive

Total Raised


Last Raised

$34M | 8 yrs ago

About Green Biologics

Green Biologics is an industrial biotechnology company focused on the production of renewable n-butanol and other C4 chemicals from various renewable feedstocks, including sugar (cane, molasses, beets), starch (corn) and cellulosic biomass (corn residues, sugar cane bagasse, forest materials and grasses). The company works with feedstock partners to deliver capital efficient production models, and works with downstream partners to deliver high quality, competitively priced products. Green Biologics' focus is on the global renewable chemicals and biofuels markets.

Headquarters Location

80F Park Drive, Milton Park Abingdon

Oxon, OX14 4RY,

United Kingdom

+44 1235 435710

Missing: Green Biologics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Green Biologics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Green Biologics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Green Biologics is included in 3 Expert Collections, including Synthetic Biology.


Synthetic Biology

305 items

Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.


Advanced Materials

1,276 items

Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.


Renewable Energy

2,899 items

Includes companies working on technology to support renewable energy generation.

Green Biologics Patents

Green Biologics has filed 11 patents.

The 3 most popular patent topics include:

  • Clostridia
  • Clostridiaceae
  • EC 4.1.1
patents chart

Application Date

Grant Date


Related Topics




Molecular biology, Genetics, Biotechnology, Genetic engineering, Molecular genetics


Application Date


Grant Date



Related Topics

Molecular biology, Genetics, Biotechnology, Genetic engineering, Molecular genetics



Latest Green Biologics News

Green Biologics capte un VC français

Jan 9, 2022

Partager - 1 conseil La biotech britannique fabriquant du butanol à partir de déchets végétaux signe un second tour significatif de... La biotech britannique fabriquant du butanol à partir de déchets végétaux signe un second tour de 18,5 M€ mené par Sofinnova, qui mise 7,5 M€, suivi par Swire Pacific Group et les VCs historiques.Si les VCs étrangers investissent parfois dans l'Hexagone (lire Que pèsent les VCs étrangers en France ? 19/11/13), les capital-risqueurs français parient aussi hors de nos frontières. Sofinnova, le fonds dédié aux sciences de la vie vient de miser 7,5 M€ dans le second tour de table de 15,4 M£ (soit 18,5 M€) de la biotech verte britannique Green Biologics. La levée de fonds est également suivie par le conglomérat anglo-hong-kongais Swire Pacific Group (3,75 M€), et complétée par les actionnaires historiques de la société à savoir (...) Cet article est réservé à nos abonnés. 83% reste à lire Pour accéder à cet article, à l'ensemble du site ainsi qu'à nos bases de données, découvrez nos formules d'abonnement .

Green Biologics Frequently Asked Questions (FAQ)

  • When was Green Biologics founded?

    Green Biologics was founded in 2003.

  • Where is Green Biologics's headquarters?

    Green Biologics's headquarters is located at 80F Park Drive, Milton Park, Oxon.

  • What is Green Biologics's latest funding round?

    Green Biologics's latest funding round is Debt.

  • How much did Green Biologics raise?

    Green Biologics raised a total of $112.7M.

  • Who are the investors of Green Biologics?

    Investors of Green Biologics include Swire Pacific, Sofinnova Partners, Tennenbaum Capital Partners, Oxford Capital Partners, Capricorn Partners and 6 more.

  • Who are Green Biologics's competitors?

    Competitors of Green Biologics include Minerva Biotechnologies, Bone Biologics, Agrivida, OPX Biotechnologies, Variation Biotechnologies and 10 more.

Compare Green Biologics to Competitors

Agrivida Logo

Agrivida is an agricultural biotechnology company developing energy crops designed to produce chemicals, fuels, and bioproducts from non-food cellulosic biomass. The company's approach is designed to provide an integrated solution for delivering the lowest-cost sugars that are essential for industrial bioproducts. The basis of Agrivida's integrated solution is engineering the feedstock to contain cell wall-degrading enzymes, and other valuable traits, which are activated following harvest. Agrivida plans to commercialize its platform through alliances across the bioindustrial product supply chain.

Laureate Pharma

Laureate Pharma, Inc. is a full service contract manufacturing organization(CMO) providing development and cGMP manufacturing services in the company's FDA registered facilities in Princeton, New Jersey. The company is dedicated to supporting the development and commercialization of biopharmaceutical, drug and diagnostic products for pharmaceutical, diagnostic and biotech companies.The company aims to provide a range of product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The company's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply.The company view the company's customers as partners and provide them with flexible solutions that reduce time to clinic and market. Focused on operational excellence, the company's highly experienced staff works with the company's customers to improve the quality of their products and processes.The company value the company's customers, stakeholders and associates. Therefore, the company measure the company's success by meeting the company's customers' needs, generating results in terms of quality, timeliness and on budget performance, as well as fostering an environment of trust, growth and diversity for the company's team.


ProtAffin is a pre-clinical biotechnology company developing protein-based products countering inflammation. Its biologics targets the heparin-like glycan structures that drive inflammatory processes.

OrgSyn Laboratory

OrgSyn is geared towards providing services to pharmaceutical companies, biotech industries and specialty chemicals by developing processes for Active Pharmaceutical Intermediates (APIs) and providing intermediates and starting material for health care industry.

Akron Biotechnology

Akron Biotechnology provides its customers with quality raw materials and components for research and development. As a scientific product supplier, the company specializes in manufacturing and supplying chemicals, biochemicals, cell culture, and cell biology products aimed at the biopharmaceutical and biotechnology markets.


Excelsyn integrate specialist management consulting, chemistry and engineering to offer a range of solutions that can enhance performance across the whole pharmaceuticals, biotech and chemicals value chain.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.